In summary, we show for the first time that tumor cell–expressed NRP1 forms complexes with VEGFR2 expressed by the endothelium (trans) in human RCC tumors, and halts tumor angiogenesis, thereby improving patient survival. Here, NRP1 is linked to renal cell carcinoma.